España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Annovis Bio
ANVS
NYSE
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$2.13
-0.10
-4.48%
At close: -
$2.15
0.02
0.94%
After Hours: 7:23 PM EDT
Get Report
Comment
Annovis Bio (ANVS) Forecast
News
Earnings
Annovis Bio (ANVS) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Annovis Bio (NYSE:ANVS) Stock
Annovis Bio Stock (NYSE: ANVS)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, February 10, 2025
Annovis Bio shares are trading lower after D....
Benzinga Newsdesk
D. Boral Capital Downgrades Annovis Bio to Ho...
Benzinga Newsdesk
Wednesday, February 05, 2025
Annovis Bio Announces That The First Two Pati...
Benzinga Newsdesk
Monday, February 03, 2025
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
Annovis Bio shares are trading lower after th...
Benzinga Newsdesk
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
Annovis Bio Prices $21M Public Offering Of 5....
Benzinga Newsdesk
Reported Friday, Annovis Bio Proposed Public ...
Benzinga Newsdesk
Tuesday, January 14, 2025
Annovis Bio Granted U.S. Patent For Buntaneta...
Benzinga Newsdesk
Tuesday, January 07, 2025
Annovis Bio Announces The FDA Has Accepted An...
Benzinga Newsdesk
Monday, November 11, 2024
D. Boral Capital Maintains Buy on Annovis Bio...
Benzinga Newsdesk
Annovis Bio shares are trading lower after th...
Benzinga Newsdesk
Annovis Bio Q3 EPS $(0.97) Misses $(0.38) Est...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Annovis...
Benzinga Newsdesk
Wednesday, October 16, 2024
Annovis Bio shares are trading higher. HC Wai...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Annovis...
Benzinga Newsdesk
Tuesday, October 15, 2024
EF Hutton Maintains Buy on Annovis Bio, Maint...
Benzinga Newsdesk
Annovis Bio shares are trading higher after t...
Benzinga Newsdesk
FDA Clears Annovis To Begin Pivotal Phase 3 A...
Benzinga Newsdesk
Tuesday, October 01, 2024
HC Wainwright & Co. Reiterates Buy on Annovis...
Benzinga Newsdesk
Monday, September 30, 2024
Annovis Files Three New Patents For Combinati...
Benzinga Newsdesk
Thursday, August 15, 2024
EF Hutton Maintains Buy on Annovis Bio, Maint...
Benzinga Newsdesk
Annovis Bio shares are trading higher. The co...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Annovis...
Benzinga Newsdesk
Annovis Bio Q2 2024 GAAP EPS $(0.44) Misses $...
Benzinga Newsdesk
Tuesday, August 13, 2024
EF Hutton Initiates Coverage On Annovis Bio w...
Benzinga Newsdesk
Thursday, August 08, 2024
Editas Q2 Earnings & Revenues Miss Estimates, Stock Down
Zacks
Tuesday, August 06, 2024
Annovis Announces Preclinical Data Demonstrat...
Benzinga Newsdesk
Wednesday, July 24, 2024
Annovis Bio Secures U.S. Patent For Treatment...
Benzinga Newsdesk
Wednesday, July 17, 2024
HC Wainwright & Co. Reiterates Buy on Annovis...
Benzinga Newsdesk
Tuesday, July 16, 2024
Annovis Bio Granted FDA Approval To Transitio...
Benzinga Newsdesk
Monday, July 15, 2024
Immutep Up as Combo Therapy Meets Carcinoma Study Goals
Zacks
Thursday, July 11, 2024
Costco To Rally More Than 10%? Here Are 10 Top Analyst Forecasts For Thursday
Avi Kapoor
HC Wainwright & Co. Maintains Buy on Annovis ...
Benzinga Newsdesk
Wednesday, July 10, 2024
UniQure Soars on New Huntington's Disease Study Data
Zacks
Why SeaStar Medical Holding Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
Tuesday, July 09, 2024
Annovis Bio Shares Resume Trade
Benzinga Newsdesk
Annovis Shares Halted On Circuit Breaker To D...
Benzinga Newsdesk
Friday, July 05, 2024
Why NIO Shares Are Trading Lower By Over 8%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Avi Kapoor
Wednesday, July 03, 2024
Peering Into Annovis Bio's Recent Short Interest
Benzinga Insights
What's Going On With Annovis Shares Today?
Nabaparna Bhattacharya
Tesla, Paramount Global, Annovis Bio, Eli Lilly, Amazon: Why These 5 Stocks Are On Investors' Radars Today
Benzinga Neuro
Tuesday, July 02, 2024
Annovis Bio Shares Halted On Circuit Breaker ...
Benzinga Newsdesk
Rodman & Renshaw Reiterates Buy on Annovis Bi...
Benzinga Newsdesk
What's Going With Annovis Bio Shares Tuesday?
Dylan Berman
Annovis Bio Announces Phase III Study Results...
Benzinga Newsdesk
Friday, June 28, 2024
Merck's New Pneumococcal Jab Capvaxive Gets CDC Panel Vote
Zacks
Thursday, June 27, 2024
Novo Nordisk's Hypertension Drug Study Fails to Meet Goal
Zacks
Annovis Bio Files Provisional Patent For New ...
Benzinga Newsdesk
Wednesday, June 26, 2024
Annovis Bio Files New Patent for Novel Solid ...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
